2010
Vocational outcomes
Resnick S, Rosenheck R. Vocational outcomes. 2010, 120-132. DOI: 10.1017/cbo9780511712265.008.Peer-Reviewed Original ResearchAntipsychotic TrialsMental health policy makersDouble-blind conditionsClinical Antipsychotic TrialsIntervention Effectiveness (CATIE) projectHealth policy makersAntipsychotic medicationAntipsychotic drugsKey treatmentComparative effectivenessMental healthSchizophreniaNational InstituteU.S. National InstituteMedicationsLandmark studiesVocational outcomesPsychiatric researchersTrialsDrugsPharmaceutical companiesSpecific outcomesOutcomesStatistical analysisClinicians
2008
Employment Outcomes in a Randomized Trial of Second-Generation Antipsychotics and Perphenazine in the Treatment of Individuals with Schizophrenia
Resnick SG, Rosenheck RA, Canive JM, De Souza C, Stroup TS, McEvoy J, Davis S, Keefe R, Swartz M, Lieberman J. Employment Outcomes in a Randomized Trial of Second-Generation Antipsychotics and Perphenazine in the Treatment of Individuals with Schizophrenia. The Journal Of Behavioral Health Services & Research 2008, 35: 215-225. PMID: 18246429, DOI: 10.1007/s11414-007-9101-3.Peer-Reviewed Original ResearchConceptsFirst-generation antipsychotic medicationsSecond-generation antipsychotic medicationsAntipsychotic medicationPsychosocial rehabilitationSecond-generation antipsychoticsDiagnosis of schizophreniaSpecific antipsychotic medicationsTreatment of individualsCATIE resultsMedication groupMedication assignmentService useQuarterly interviewsMedicationsSchizophreniaOutcomesTrialsPerphenazineEmployment outcomesGreat benefitIndividualsAntipsychoticsMixed results